Workflow
迈瑞医疗收盘上涨1.42%,滚动市盈率25.09倍,总市值2794.80亿元

Company Overview - Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in the research, manufacturing, marketing, and service of medical devices [1] - The main products include life information and support products, in vitro diagnostic products, medical imaging products, electrophysiology and vascular intervention products, and other products [1] Financial Performance - As of Q1 2025, the company reported revenue of 8.237 billion yuan, a year-on-year decrease of 12.12% [1] - The net profit for the same period was 2.629 billion yuan, reflecting a year-on-year decline of 16.81% [1] - The gross profit margin stood at 62.53% [1] Market Position - The company's stock closed at 230.51 yuan, with a PE ratio of 25.09 times, while the average PE ratio in the medical device industry is 48.81 times [1][2] - Mindray ranks 57th in terms of PE ratio within its industry [1] - The total market capitalization of the company is 279.48 billion yuan [1][2] Institutional Holdings - As of Q1 2025, a total of 323 institutions hold shares in Mindray, including 315 funds, 5 other institutions, and 3 brokerages, with a total shareholding of 93.7632 million shares valued at 219.406 billion yuan [1]